Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
Filippo Pinto E VairoMatthew J KosterJennifer L KemppainenBrittany C ThomasKenneth J WarringtonPublished in: Rheumatology (Oxford, England) (2021)
Keyphrases